Re: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of the National Cancer Institute

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/jnci/95.13.1011PMID 12837842
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

  2002cited by this paper
• Clinical and pathological features of BRCA1 associated carcinomas in a hospital-based sample of Dutch breast cancer patients

  2001cited by this paper
• Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies

  1996cited by this paper
• Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence.

  1995cited by this paper
• ON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASE

  1955cited by this paper

• [Identification and management of hereditary breast-ovarian cancers (2004 update)].

  2004cites this paper
• [Identification and management of hereditary predisposition to cancer of the breast and the ovary (update 2004)].

  2004cites this paper